Genelux Common Stock Annual Yield
| GNLX Stock | 2.52 0.07 2.70% |
Genelux Common fundamentals help investors to digest information that contributes to Genelux Common's financial success or failures. It also enables traders to predict the movement of Genelux Stock. The fundamental analysis module provides a way to measure Genelux Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genelux Common stock.
Genelux | Annual Yield |
Genelux Common Company Annual Yield Analysis
Genelux Common's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Genelux Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Genelux Common is extremely important. It helps to project a fair market value of Genelux Stock properly, considering its historical fundamentals such as Annual Yield. Since Genelux Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Genelux Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Genelux Common's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Genelux Common has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Genelux Common ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Genelux Common's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Genelux Common's managers, analysts, and investors.Environmental | Governance | Social |
Genelux Fundamentals
| Return On Equity | -0.89 | ||||
| Return On Asset | -0.45 | ||||
| Current Valuation | 57.44 M | ||||
| Shares Outstanding | 34.54 M | ||||
| Shares Owned By Insiders | 16.28 % | ||||
| Shares Owned By Institutions | 15.70 % | ||||
| Number Of Shares Shorted | 1.62 M | ||||
| Price To Book | 2.63 X | ||||
| Price To Sales | 11,182 X | ||||
| Revenue | 170 K | ||||
| Gross Profit | 11.07 M | ||||
| EBITDA | (26.46 M) | ||||
| Net Income | (28.3 M) | ||||
| Total Debt | 2.52 M | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (20.27 M) | ||||
| Short Ratio | 8.90 X | ||||
| Earnings Per Share | (0.94) X | ||||
| Target Price | 18.4 | ||||
| Number Of Employees | 24 | ||||
| Market Capitalization | 89.45 M | ||||
| Total Asset | 27.89 M | ||||
| Retained Earnings | (221.52 M) | ||||
| Working Capital | 17.65 M | ||||
| Net Asset | 27.89 M |
About Genelux Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genelux Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genelux Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genelux Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.